$46.28 $0.11 (0.2%)

04:00 PM EST on 11/13/19

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Current Price $46.28 Mkt Cap $2.3B
Open $45.82 P/E Ratio 4.13
Prev. Close $46.17 Div. (Yield) $0.00 (0.0%)
Daily Range $45.37 - $46.65 Volume 287,904
52-Wk Range $38.18 - $64.48 Avg. Daily Vol. 375,816

Caps

How do you think NASDAQ:ARNA will perform against the market?

Add Stock to CAPS Watchlist

All Players

767 Outperform
75 Underperform
 

All-Star Players

87 Outperform
20 Underperform
 

Wall Street

7 Outperform
6 Underperform
 

Top NASDAQ:ARNA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

rteberg (< 20)
Submitted January 23, 2013

Weight loss drug will have great acceptance in the market

opgenortht (< 20)
Submitted April 22, 2010

obesity market for drugs without significant sustained weight loss - greater than 10% - is impossible to penetrate without gigantic consumer-directed, expensive, advertising....remember 10% for a 250lb person is 25lb bringing their new weight to… More

NASDAQ:ARNA VS S&P 500 (SPY)

Fools bullish on NASDAQ:ARNA are also bullish on:

Fools bearish on NASDAQ:ARNA are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ARNA.

Recs

0
Member Avatar FVelociraptor (99.92) Submitted: 9/28/2019 8:32:34 PM : Underperform Start Price: $45.41 NASDAQ:ARNA Score: +2.53

https://velociraptor.cc

Recs

0
Member Avatar Capitalism (77.98) Submitted: 9/19/2018 11:51:53 AM : Outperform Start Price: $41.93 NASDAQ:ARNA Score: +4.33

bulwnkl from Saul's MF msg board

Recs

0
Member Avatar TMFEBCapital (80.63) Submitted: 2/15/2018 12:02:45 PM : Outperform Start Price: $39.94 NASDAQ:ARNA Score: +1.67

Big potential catalyst on deck in the form of results from a mid stage trial evaluating a drug with the same mechanism of action as Celgene's ozanimod. If ARNA's trial is a success, shares are likely to trade meaningfully higher. A disappointment could cause a plunge, though, so buyer beware.

Leaderboard

Find the members with the highest scoring picks in ARNA.

Score Leader

bluemoth

bluemoth (< 20) Score: +757.14

The Score Leader is the player with the highest score across all their picks in ARNA.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
PacificSexLegend 94.75 6/19/2009 Underperform 5Y $53.70 -13.82% +235.50% +249.32 0 Comment
bmswbc 91.95 12/1/2008 Underperform 3M $35.10 +31.85% +268.70% +236.85 0 Comment
ShortItNow 42.17 8/30/2006 Underperform 3M $118.90 -61.08% +151.62% +212.69 0 Comment
marianeaj1 < 20 8/4/2010 9/14/2010 Underperform 3W $73.20 -36.78% +174.70% +211.48 0 Comment
mimiaj 69.18 8/4/2010 9/10/2010 Underperform 3W $73.20 -36.78% +174.70% +211.48 0 Comment
foolergo8888 29.45 8/3/2010 Underperform 5Y $69.00 -32.93% +174.82% +207.75 0 Comment
Sempre57 27.39 11/7/2006 Underperform 3M $155.70 -70.28% +136.77% +207.05 0 Comment
lowrider61 67.74 12/4/2006 Underperform NS $130.60 -64.56% +133.93% +198.50 0 Comment
ozarksmart < 20 12/22/2006 Underperform 1Y $135.70 -65.90% +132.58% +198.48 0 Comment
Doughboy49 32.09 12/8/2006 Underperform 1Y $134.80 -65.67% +132.53% +198.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARNA.